CompuGroup Med Action Forum

Analsyst updates, 08.11.

⬆️⬆️⬆️

- GOLDMAN upgrades BIONTECH from Neutral to Buy and raises price target from USD 90 to USD 137. $BNTX (+3,76 %)

- BOFA raises target price for UNDER ARMOUR from USD 9 to USD 13. Neutral. $UAA (-12,43 %)

- DEUTSCHE BANK RESEARCH raises the price target for DELIVERY HERO from EUR 29 to EUR 35. Hold. $DHE

- DEUTSCHE BANK RESEARCH raises the price target for SIEMENS from EUR 197 to EUR 200. Buy. $SIE (-2,51 %)

- JEFFERIES raises the price target for HOCHTIEF from EUR 135 to EUR 138. Buy. $HOT (-1,48 %)

- DEUTSCHE BANK RESEARCH raises the price target for SIEMENS HEALTHINEERS from EUR 60 to EUR 62. Buy. $SHL (-1,29 %)

- DEUTSCHE BANK RESEARCH raises the price target for NORDEX from EUR 18 to EUR 19. Buy. $NDX1 (-0,04 %)

- DEUTSCHE BANK RESEARCH raises the price target for RATIONAL from 832 EUR to 841 EUR. Hold. $RAA (+2,46 %)

- DEUTSCHE BANK RESEARCH raises the target price for AXA from 37 EUR to 39 EUR. Buy. $CS (-1,29 %)

- WARBURG RESEARCH raises the price target for BASTEI LÜBBE from EUR 11.70 to EUR 12.20. Buy. $BST (-0,52 %)

- DEUTSCHE BANK RESEARCH raises the price target for ARCELORMITTAL from EUR 28 to EUR 29. Buy. $MT (-1,08 %)

- DZ BANK raises the price target for SWISS RE from CHF 130 to CHF 140. Buy. $SREN (-0,8 %)

- ODDO BHF raises the price target for HEIDELBERG MATERIALS from EUR 99 to EUR 110. Neutral. $HEI (+1,13 %)

- KEPLER CHEUVREUX raises the price target for DAIMLER TRUCK from EUR 35 to EUR 41. Hold. $DTG (-4,27 %)

- KEPLER CHEUVREUX upgrades REDCARE PHARMACY from Reduce to Hold. $RDC (+9,53 %)

- ODDO BHF raises the price target for HENKEL from EUR 67 to EUR 73. Neutral. $HEN (+0,21 %)

- ODDO BHF raises the price target for FREENET from EUR 27 to EUR 28. Neutral. $FNTN (+4,72 %)

- BARCLAYS raises the target price for ABOUT YOU from EUR 3.10 to EUR 3.40. Underweight. $YOU (-6,6 %)

- BARCLAYS raises the target price for NEMETSCHEK from EUR 108 to EUR 125. Overweight. $NEM (-0,52 %)

⬇️⬇️⬇️

- BOFA lowers the price target for PINTEREST from USD 45 to USD 39. Buy. $PINS

- WARBURG RESEARCH lowers the price target for DAIMLER TRUCK from EUR 56 to EUR 55. Buy. $DTG (-4,27 %)

- UBS lowers the price target for JCDECAUX from EUR 21.60 to EUR 18.50. Neutral. $DEC (-12,18 %)

- WARBURG RESEARCH lowers the price target for ADTRAN HOLDING from EUR 9.70 to EUR 9.30. Buy. $ADTN (+7,68 %)

- ODDO BHF lowers the price target for NORDEX from EUR 18 to EUR 17. Outperform. $NDX1 (-0,04 %)

- BARCLAYS lowers the target price for VESTAS from DKK 99 to DKK 80. Underweight. $VWS (-2,71 %)

- KEPLER CHEUVREUX lowers the price target for FRAPORT from EUR 62 to EUR 59. Buy. $FRA (+2,15 %)

- BARCLAYS lowers the target price for GSK from GBP 15.50 to GBP 14.50. Equal-Weight. $GSK

- BERENBERG lowers the price target for COMPUGROUP from EUR 23 to EUR 21. Buy. $COP (-0,13 %)

- BERENBERG lowers the price target for JUNGHEINRICH from EUR 41 to EUR 39. Buy. $JUN3 (-0,16 %)

- JEFFERIES lowers the target price for SUSS MICROTEC from EUR 87 to EUR 75. Buy. $SMHN (+1,16 %)

Summary Earnings, 07.11.

$MUV2 (-0,5 %)
| Munich Re Q3 24 Earnings

EPS EU7.02 (est EU6.67)

Sees FY Insurance Rev. About EU61B, Saw About EU59B

Sees FY Profit Above EU5B, Saw EU5B

$RHM (+1,63 %) | Rheinmetall AG Q3 24 Earnings

Sales EU2.45B (est EU2.42B)

Still Sees FY Sales About EU10B (est EU9.99B)

Sees FY Operating Margin At Upper End Of Guidance

Nissan Motor Q2 2024 Earnings $7201 (+0,06 %)

Q2 Operating Income 31.91B Yen (est 65.25B Yen)

Q2 Net Loss 9.34B Yen (est Profit 49.07B Yen)

Sees FY Oper Income 150.00B Yen, Saw 500.00B Yen

To Cut 9,000 Jobs Globally

To Reduce Global Production Capacity By 20%

To Sell Back Up To 10.02% Of Mitsubishi Motors Shares

Air France KLM Q3 24 Earnings $AF

EBITDA EU1.90B (est EU1.9B)

Rev EU8.98B (est EU8.88B)

Net Income EU780M (est EU874.3M)

Sees FY Capex EU3B, Saw Below EU3B

$TEF (+1,75 %) | Telefonica Q3 24 Earnings

REV. EU10.02B (est EU10B)

Adj. EBITDA EU3.26B (est EU3.26B)

Net Income EU10M (est EU357M)

To Book €314 Million Non-Cash Impairment For Peru

ArcelorMittal Q3 24 Earnings: $MT (-1,08 %)

- Sales $15.20B (est $15.23B)

- EBITDA $1.58B (est $1.47B)

- Still Sees FY CAPEX $4.5B To $5.0B

- Markets Conditions Are 'Unsustainable'

- Positive On Medium/Long Term Outlook

Daimler Truck Holdings Q3 24 Earnings: $DTG (-4,27 %)

- Rev EU13.14B (est EU12.98B)

- Adj EBIT EU1.19B (est EU1.13B)

- Still Sees FY Rev EU53B To EU55B (est EU53.45B)

Adyen disappoints with lower than expected sales growth and loses 13% on the stock market. $ADYEN (-4,7 %)

Lanxess-shares rise by 4.4% to 26.80 euros after a positive quarterly report, having previously fallen by 13%. The operating margin exceeds expectations, although prices weaken. $LXS (-3,58 %)

National Grid increased its adjusted operating profit by 14% to 2 billion pounds in the first half of the financial year and expects an increase of around 10% for the year as a whole. Higher fees in New York and higher revenues in the UK are supporting growth. $NG. (-0,42 %)

AMS-Osram increased its profitability in the third quarter despite a decline in sales, but expects business development to be subdued in the fourth quarter and early 2025. To ensure profitability, the company plans further cost reductions of 225 million euros by the end of 2026. $AMS

Suess Microtec is more optimistic after a strong third quarter and now expects to achieve its annual targets in the upper half of the forecast range. Sales are expected to reach 380 to 410 million euros, with an EBIT margin of 14 to 16 percent. $SMHN (+1,16 %)

The investment company Mutares slips into the red operationally in the third quarter with an adjusted EBITDA loss of EUR 16.5 million. However, sales increased by 14% to 3.9 billion euros. $MUX (-3,12 %)

Delivery Hero expects a free cash flow of EUR 50 to 100 million for 2024 and anticipates GMV growth at the upper end of the forecast of 7 to 9 percent. However, the Group expects adjusted EBITDA to be at the lower end of the range of EUR 725 to 775 million. $DHE

Deutz recorded an 80% drop in profits to EUR 7.2 million in the third quarter and slipped into the red with a bottom line of EUR 2 million. Turnover falls by 14.9% to 430.4 million euros due to a slump in demand. $DEZ (-3,78 %)

Compugroup Medical records a decline in EBITDA in the third quarter

EBITDA fell by 12% to 54.9 million euros in the third quarter, but slightly exceeded

analysts' expectations slightly. Turnover falls by 1% to 283.4 million euros

euros, and the company confirms its reduced forecast for 2024. $COP (-0,13 %)

Alzchem reports a jump in profits for the first nine months with

a 36% increase in EBITDA to EUR 76.8 million and increases the EBITDA margin to

EBITDA margin to 18.5 %. The Group is sticking to its profit target for 2024

but is aiming for the lower end of the sales forecast due to the discontinuation of low-margin

the lower end of the sales forecast. $ACT (-2,51 %)

Nordex is raising its forecast for the EBITDA margin for 2024 and

now expects it to be closer to the upper end of the range of three to four

percent. In the first nine months of the year, the company recorded

an increase in revenue of 14 percent to EUR 5.1 billion and an improved

improved EBITDA margin of 3.7 percent. $NDX1 (-0,04 %)

Nemetschek recorded an increase in revenue in the third quarter thanks to the

thanks to the GoCanvas acquisition, Nemetschek recorded a 15.1% increase in revenues to 253 million euros,

however, earnings remained slightly below expectations. The

The operating costs of the acquisition put pressure on profits, so that EBITDA

increases by 6.7 %. $NEM (-0,52 %)

Rational increases earnings before interest and taxes in the third quarter

taxes by 18% to just under 78 million euros, exceeding analysts'

analysts' expectations, while sales revenues grew by 8% to 294 million

euros. The company confirms its forecast for the year. $RAA (+2,46 %)

$COP (-0,13 %)

Hello everyone,

How do you see it?

Since the last price slide, the share has been moving sideways for a few weeks.

Has the bottom been reached?

Have you already used the first tranches to enter the market?

The fact is that the medical sector has to invest in order to stay in the market. But it is also a fact that hospitals etc. Hospitals etc. are also suffering from cost pressure, which is why investments in the future tend to be avoided!

A small position $COP (-0,13 %) built up. I am counting on a positive development here in the future, especially in view of the pending digitalization of the electronic health card and the associated equipment with readers in doctors' surgeries across Europe.

Why Europe-wide? Well, the EU is currently pushing ahead with a number of projects aimed at creating the technical prerequisites for being able to read the electronic health card in every EU country. Someone has to supply the technology and software for this and this is where $COP (-0,13 %) ahead.

If I am right, there should still be a lot of potential and I am long here due to the long-term service contracts. Of course, I am also happy to take the high dividend yield of over 6%.

Of course, this is just my opinion and should not be seen as an investment recommendation. Do with your money what you think is right.

Economy on 22.05.2024...

Markets take a breath near the ATH. A lot going on today. Paypal AGM, Nvidia figures and so on... ⤵️

There has been a lot going on in the last few weeks. Nevertheless, trading went very well and I still have a few positions open.

I'll take a long look at Hugo Boss after the figures and the co-op with David Beckham.

I have gone long on some solar stocks and I am still working on a turnaround $VNA (+2,7 %) Vonovia, $PYPL (+3 %) Paypal and $PAH3 (-2,05 %) Porsche.

Closed trades of the last weeks are:

$BAYN (-1,69 %) Bayer, $ADE (-0,5 %) Bitcoin Group, $JNJ (+0,03 %) Johnson & Johnson, $FME (+1,22 %) Fresenius Medical Care and $AFX (-2,96 %) Carl Zeiss

My savings plans on the ETFs are continuing and otherwise I am building up a lot of cash in order to be able to participate in one or two setbacks

Cryptos have also started well again, especially Ethereum, after the chances of an ETH ETF being approved rose to 75%.

Let's take a look at today's trading day and the dates. There are a few general meetings that are interesting. Paypal, McDonalds and so on, among others. See for yourself:

Singapore stock market holiday

Economic data

08:00

• UK: Consumer prices April PROGNOSE: +0.2% yoy/+2.1% yoy previous: +0.6% yoy/+3.2% yoy Core PROGNOSE: +0.7% yoy/+3.6% yoy previous: +0.6% yoy/+4.2% yoy

10:05

• EU: ECB President Lagarde, video message for Esma event on Capital Markets Union

16:00

• US: Existing Home Sales April PROGNOSE: +1.4% yoy previous: -4.3% yoy

16:30

• US: Crude Oil Inventories EIA

20:00

• US: Fed, minutes of the FOMC meeting April 30/May 1

ex-dividend of individual stocks

Renault EUR 1.85

Quarterly figures / company dates USA / Asia

16:00 $MCD (+2,19 %)
McDonalds | $MDLZ (+1,41 %)
Mondelez

16:00 $UAL (+3,22 %)
United Airlines AGM

16:30 US: Crude Oil Inventories EIA

17:00 PayPal AGM

18:00 $AMZN (-0,02 %)
Amazon AGM

22:20 $NVDA (-0,03 %)
Nvidia quarterly figures

Quarterly figures / Company dates Europe

07:00 $EVT (-0,84 %)
Evotec | $HBH (-1,52 %)
Hornbach Holding

10:00 $COP (-0,13 %)
Compugroup Medical AGM

10:30 Indus Holding AGM

11:00 $PUMA (-0,33 %)
Puma AGM

14:00 Evotec Earnings-Call

Untimed: Einhell quarterly figures

Quarterly figures on 03.11.2022...

Feel free to leave a follow, because...⤵️

...at 5,000 followers there will be together with getquin, a small thank you for the community. But this post could already be created tomorrow. I look forward to it! On to today's quarterly numbers. In this post that I post every morning, I had announced what was happening today:

https://app.getquin.com/activity/ydggsOLkpb?lang=de&utm_source=sharing

$SBUX (+2,49 %)
Starbucks:

Beat analyst estimates of $0.73 in the fourth quarter with earnings per share of $0.81. Revenue of $8.4 billion beat expectations of $8.33 billion.

$PYPL (+3 %)
PayPal:

Beats analyst estimates of $0.96 in the third quarter with earnings per share of $1.08. Revenue of $6.85 billion beats expectations of $6.82 billion.

$DBX (-2,25 %)
Dropbox:

Beat analyst estimates of $0.38 in the third quarter with earnings per share of $0.43. Revenue of $591 million exceeded expectations of $586.15 million.

$DASH (+1,74 %)
DoorDash:

Missed analyst estimates of -$0.55 in the third quarter with earnings per share of -$0.77. Revenue of $1.7 billion exceeded expectations of $1.62 billion.

$GPRO (+8,21 %)
GoPro:

Beat analyst estimates of $0.17 in the third quarter with earnings per share of $0.19. Revenue of $305 million exceeded expectations of $298.85 million.

$MSI (+8,83 %)
Motorola Solutions:

Beats third-quarter analyst estimates of $2.88 with earnings per share of $3.00. Revenue of $2.37 billion beats expectations of $2.31 billion.

$HOT (-1,48 %)
Hochtief:

Reached sales of 7.18 billion euros in the third quarter, up from 5.32 billion a year earlier, and earned 115 million euros on the bottom line, up from 99.8 million a year earlier. Order intake on a comparable basis was 6.5 billion (prior year 7.5 billion).

$K (+1,27 %)
Kellogg Co:

Surpassed analysts' estimates of $0.97 in the third quarter with earnings per share of $1.01. Sales of $3.95 billion exceeded expectations of $3.77 billion.

$RCL (+2,93 %)
Royal Caribbean Cruises Ltd:

Beat analyst estimates of $0.19 in the third quarter with earnings per share of $0.26. Revenue of $3 billion exceeded expectations of $2.99 billion.

$UAA (-12,43 %)
Under Armour Inc:

Second-quarter earnings per share of $0.20 beat analyst estimates of $0.10. Revenue of $1.57 billion exceeded expectations of $1.42 billion.

$W (-1,95 %)
Wayfair Inc:

Missed analyst estimates of -$2.05 in the third quarter with earnings per share of -$2.11. Revenue of $2.8 billion below expectations of $2.82 billion.

$PTON (+11,28 %)
Peloton Interactive Inc:

Missed analyst estimates of -$0.64 with first-quarter earnings per share of -$1.20. Revenue of $616.5 million below expectations of $637.07 million.

$DDOG (-2,68 %)
Datadog Inc:

Third-quarter earnings per share of $0.23 beat analyst estimates of $0.16. Revenue of $437 million exceeded expectations of $415.07 million.

$MRNA (-5,5 %)
Moderna Inc:

Missed analyst estimates of $4.81 in the third quarter with earnings per share of $2.53. Revenue of $3.36 billion below expectations of $4.63 billion.

$CROX (-0,45 %)
Crocs Inc:

Missed analyst estimates of $2.62 in the third quarter with earnings per share of $2.50. Revenue of $985.1 million exceeded expectations of $942.52 million.

$IRM (+3,19 %)
Iron Mountain Inc:

Third-quarter earnings per share of $0.48 beat analyst estimates of $0.44. Sales of $1.29 billion below expectations of $1.31 billion.

$SBS (-1,99 %)
STRATEC:

Posts Q1-3 sales of €207.7 million (preliminary: €207.7 million), adjusted EBIT margin of 18.3% (preliminary: 18.3%), and net income (adjusted) of €29.5 million (PY: €40.6 million). Outlook confirmed.

$BOSS (-3,01 %)
HUGO BOSS:

Achieves Q3 sales of €933 million (PY: €755, analyst forecast: €903.4 million), EBIT of €92 million (PY: €85 million, forecast: €88.1 million) and net income of €58 million (PY: €53 million, forecast: €56.6 million). In the outlook for 2022, the company now expects sales of €3.5 to €3.6 billion (previous: €3.3 to €3.5 billion) and EBIT of €310 to €330 million (previous: €285 to €310 million).

$SGL (+0,82 %)
SGL CARBON:

Achieves Q1-3 sales of €853.9 million (previous year: €743.5 million), Ebitda (adjusted) of €136.1 million (previous year: €108.5 million) and net income after minorities of €70.6 million (previous year: €42.6 million). Forecast confirmed.

$PFV (-0,39 %)
Pfeiffer Vacuum:

Achieves Q1-3 order intake of €866.5 million (preliminary: €866.5 million), sales of €668.7 million (preliminary: €668.7 million), EBIT of €94 million (preliminary: €94 million) and net income of €66.6 million (PY: €52.1 million). October 17 forecast for revenue and Ebit margin confirmed.

$HNR1 (-0,46 %)
Hannover Re:

Achieves 3. Gross premiums written of €8.91 billion (PY: €7.15 billion, analyst forecast: €8.02 billion), combined ratio of 99.6% (PY: 101.5%, forecast: 99.6%), investment result of €400.3 million (PY: €491.1 million), an Ebit of €408.9 million (PY: €324.5 million, forecast: €399 million) and a net profit of €221.9 million (PY: €185.4 million, forecast: €311 million). In the outlook for 2022, the company sees net income in the lower range of €1.4 billion to €1.5 billion, profit target for 2022 remains achievable.

$UN01
Uniper:

Achieves 1st to 3rd. Quarter net result of -€40 billion (PY: -€4.8 billion), net loss includes €10 billion realized costs for replacement volumes; economic net debt at €10.91 billion (PY: €0.324 billion), net loss includes €31 billion expected losses and provisions; adjusted net loss of -€3.22 billion (preliminary: -€3.2 billion, prior year: +€0.487 billion), adjusted EBIT of -€4.75 billion (preliminary: -€4.8 billion, prior year: +€0.614 billion). Concrete earnings forecast currently impossible for the time being.

$O2D (+0,24 %)
Telefonica Germany:

Achieves Q3 sales of €2.085 billion (PY: €1.967 billion, analyst forecast: €2.030 billion), service sales of €1.47 billion (PY: €1.42 billion), adjusted OIBDA of €642 million (PY: €613 million, forecast: €640.5 million). In the outlook for 2022, sales and OIBDA are now expected to be in the "lower mid-single-digit percentage range" compared to the previous year (previously: in the "low mid-single-digit percentage range").

$BMW (-3,91 %)
BMW:

Reports Q3 sales of €37.18 billion (PY: €27.47 billion, analysts' forecast: €35.53 billion), EBIT of €3.68 billion (PY: €2.88 billion, forecast: €3.5 billion), EBT of €4.1 billion (PY: €3.42 billion) and net income of €3.18 billion (PY: €2.58 billion). Outlook confirmed.

$ZAL (+1,5 %)
Zalando:

Achieves Q3 revenues of €2.34 billion (PY: €2.28 billion), Ebit (adjusted) of €13.5 million (PY: €9.8 million) and net result of -€35.4 million (PY: -€8.4 million); number of active customers grows by 8% and exceeds 50 million for the first time. Outlook confirmed.

$COP (-0,13 %)
CompuGroup:

Posts Q1-3 revenue of €802 million (preliminary: €802 million), Ebitda of €166 million (preliminary: €166 million) and net income of €59.8 million (PY: 56.6 million). Outlook confirmed.

$RAA (+2,46 %)
RATIONAL:

Achieves Q3 sales of €274.2 million (PY: €207 million, analyst forecast: €270 million), Ebit of €70.3 million (PY: €49.7 million, forecast: €64.4 million), Ebit margin of 25.6% (PY: 24.0%) and net income of €53.8 million (PY: €37.8 million). Forecast confirmed.

$KCO (-2,66 %)
Klöckner & Co:

Achieves 3rd quarter sales of €2.37 billion (PY: €2.0 billion), Ebitda (adjusted) of €16 million (PY: €277 million) and net result of -€22 million (PY: +€185 million). Outlook confirmed.

#quartalszahlen
#boerse
#börse
#aktien
#paypal
#starbucks
#sandp500
#communityfeedback
#community

Trade

Double bottom at the golden pocket, breakout from the downtrend with subsequent consolidation at the 200TL. After this was broken under high volume I went long, this morning my price target was reached.

https://www.tradingview.com/x/VSqjyrJI

Future-oriented business. The digitization of healthcare, for which the Union wants to put 500 million euros in hand... One company that could profit from the modernization of the medical sector is Compugroup Medical. The Koblenz-based company is digitizing the healthcare sector and equipping doctors' offices, hospitals, care facilities, pharmacies, payers and others with software and information systems. The products are designed to help customers better overcome bureaucratic hurdles and make their processes more time-saving and efficient. A core element of the portfolio is the electronic patient file (ePA). It digitally collates patient data stored at various locations, such as findings, diagnoses or therapeutic measures. Compugroup not only networks, but also transfers and stores the sensitive data on German servers and offers additional digital modules for the ePA (digital video consultation, programs for staff deployment and invoice management). The ePA is central to the medical care of the future and is likely to form the technological basis of the CDU's "Digital Health 2030" project.

Another small cap that is currently flying under the radar.